Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-21-002349
Filing Date
2021-02-16
Accepted
2021-02-12 21:40:57
Documents
2
Group Members
ALTIUM CAPITAL MANAGEMENT, LPALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G blrx-sc13ga_021221.htm SC 13G/A 89091
2 JOINT ACQUISITION STATEMENT ex-1.htm EX-1 9420
  Complete submission text file 0001387131-21-002349.txt   100216
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Subject) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86614 | Film No.: 21631596
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

EIN.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A